German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved or endorsed by any other entities, such as banks, credit card issuers or ...

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

Pharma - STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty ...

Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are taking place. Peter ...

German generics and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) today released financial results, which the ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The boss of German healthcare company Stada says his business is a better bet than Big Pharma, as he tries to win over investors ahead of what could be Europe’s biggest IPO this year.

The European Commission has approved a biosimilar of the IL-12 and IL-23 inhibitor antibody developed by STADA and partner Alvotech – called Uzpurvo – for the treatment of plaque psoriasis ...

FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's equity markets.